KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Change in Acquisitions & Divestments (2016 - 2025)

Sarepta Therapeutics (SRPT) has 14 years of Change in Acquisitions & Divestments data on record, last reported at $99.9 million in Q4 2025.

  • For Q4 2025, Change in Acquisitions & Divestments fell 89.65% year-over-year to $99.9 million; the TTM value through Dec 2025 reached $295.9 million, down 85.22%, while the annual FY2025 figure was $295.9 million, 85.22% down from the prior year.
  • Change in Acquisitions & Divestments reached $99.9 million in Q4 2025 per SRPT's latest filing, up from $86.6 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $965.1 million in Q4 2024 and bottomed at $30.0 million in Q3 2021.
  • Average Change in Acquisitions & Divestments over 5 years is $308.6 million, with a median of $279.7 million recorded in 2024.
  • Peak YoY movement for Change in Acquisitions & Divestments: surged 1231.9% in 2022, then plummeted 91.47% in 2025.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at $30.0 million in 2021, then skyrocketed by 1388.34% to $446.5 million in 2022, then increased by 18.3% to $528.2 million in 2023, then surged by 82.71% to $965.1 million in 2024, then plummeted by 89.65% to $99.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Acquisitions & Divestments were $99.9 million in Q4 2025, $86.6 million in Q3 2025, and $68.6 million in Q2 2025.